{
  "Variants Include": [
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_004558.3:c.143G>A",
          "cDNA Change": {
            "transcript": "NM_004558.3",
            "ref": "G",
            "alt": "A",
            "position": "143"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "P",
            "position": "42"
          },
          "Description in input context": "R42P mutation in parkin's ubiquitin-like domain"
        },
        {
          "HGVS": "NM_004558.3:c.143G>T",
          "cDNA Change": {
            "transcript": "NM_004558.3",
            "ref": "G",
            "alt": "T",
            "position": "143"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "K",
            "position": "42"
          },
          "Description in input context": "R42K mutation in parkin's ubiquitin-like domain"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Autosomal recessive juvenile Parkinson disease",
    "MONDO": "MONDO:0008504"
  },
  "Experiment Method": [
    {
      "Assay Method": "Urea unfolding experiments",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "Parkin Ubiquitin-like domain and Ubiquitin",
        "Description": "Comparative stability analysis between parkin Ubld and ubiquitin"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004558.3:c.143G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Structural destabilization",
          "Result Description": "Parkin Ubld with R42P mutation showed 10.6 kJ/mol lower stability compared to ubiquitin"
        },
        {
          "Variant": "NM_004558.3:c.143G>T",
          "Conclusion": "Normal",
          "Molecular Effect": "No significant structural change",
          "Result Description": "K48A mutation did not affect the stability of parkin Ubld"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type parkin Ubld and ubiquitin"
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Stability difference < 5 kJ/mol compared to ubiquitin",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Stability difference â‰¥ 5 kJ/mol compared to ubiquitin",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "NMR spectroscopy",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "GB1-Ubld fusion protein",
        "Description": "Structural analysis of parkin Ubld with R42P mutation"
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_004558.3:c.143G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Complete unfolding",
          "Result Description": "R42P mutation caused complete unfolding of the Ubld domain"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type GB1-Ubld fusion protein"
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Structural integrity maintained in NMR spectra",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Structural features indicative of unfolding in NMR spectra",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}